Early Access to Medicines Scheme

The Early Access to Medicines Scheme (EAMS) aims to make promising new medicines available to patients sooner. It was set up in 2014 and is run by the Medicines and Healthcare Products Regulatory Agency (MHRA).

About the Early Access to Medicines Scheme

The Early Access to Medicines Scheme (EAMS) gives people access to promising new drugs that are not yet licensed.

Safety measures and the Early Access to Medicines Scheme

There are safety measures in place if you have a drug through the Early Access to Medicines Scheme (EAMS).

Coronavirus and cancer

We know it’s a worrying time for people with cancer, we have information to help.

Read our information about coronavirus and cancer

Early Access to Medicines Scheme

About the Early Access to Medicines Scheme

Safety measures and the Early Access to Medicines Scheme

Find a clinical trial

Cancer Chat forum

Nurse helpline 0808 800 4040